BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28072892)

  • 1. Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians.
    Maggi P; De Socio GV; Cicalini S; D'Abbraccio M; Dettorre G; Di Biagio A; Martinelli C; Nunnari G; Rusconi S; Sighinolfi L; Spagnuolo V; Squillace N
    New Microbiol; 2017 Apr; 40(2):139-142. PubMed ID: 28072892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of statins and aspirin to reduce risks of cardiovascular disease.
    Hebert PR; Pfeffer MA; Hennekens CH
    J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):77-80. PubMed ID: 12075395
    [No Abstract]   [Full Text] [Related]  

  • 3. Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use.
    Maggi P; De Socio GV; Cicalini S; D'Abbraccio M; Dettorre G; Di Biagio A; Martinelli C; Nunnari G; Rusconi S; Sighinolfi L; Spagnuolo V; Squillace N
    AIDS Res Ther; 2019 May; 16(1):11. PubMed ID: 31126301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy to prevent cardiovascular disease: slow progress.
    Smith R; McCready T; Yusuf S
    JAMA; 2013 Apr; 309(15):1595-6. PubMed ID: 23529576
    [No Abstract]   [Full Text] [Related]  

  • 5. Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians.
    Viera AJ; Sheridan SL; Edwards T; Soliman EZ; Harris R; Furberg CD
    Prev Med; 2011 Jan; 52(1):10-5. PubMed ID: 20933538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Practical prevention and treatment of cardiovascular diseases in patients with diabetes mellitus type 2 in an endocrinological department].
    Daurbekova LV; Orlov VA; Giliarevskiĭ SR; Abirova ES; Murzabekova LI
    Ter Arkh; 2004; 76(12):32-6. PubMed ID: 15724922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins in HIV-Infected Patients: Potential Beneficial Effects and Clinical Use.
    Bernal E; Marín I; Masiá M; Gutiérrez F
    AIDS Rev; 2017; 19(2):59-71. PubMed ID: 28182617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin Prescribing Practices in the Comprehensive Care for HIV-Infected Patients.
    Kelly SG; Krueger KM; Grant JL; Penugonda S; Feinstein MJ; Taiwo BO; Achenbach CJ
    J Acquir Immune Defic Syndr; 2017 Sep; 76(1):e26-e29. PubMed ID: 28520617
    [No Abstract]   [Full Text] [Related]  

  • 9. Statins and aspirin: do they really work in women?
    Desai H; Hollingsworth PW; Chugh AR
    Am J Cardiovasc Drugs; 2015 Jun; 15(3):151-62. PubMed ID: 25812803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Polypill in the prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescribing Statins to Reduce Cardiovascular Disease: 10 Common Misconceptions.
    Schade DS; Shey L; Eaton RP
    Am J Med; 2019 Aug; 132(8):897-899. PubMed ID: 30851261
    [No Abstract]   [Full Text] [Related]  

  • 12. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of aspirin and statins for the primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus infection.
    Park TE; Yusuff J; Sharma R
    Int J STD AIDS; 2016 May; 27(6):447-52. PubMed ID: 25957325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evening versus morning polypill utilization study: the TEMPUS rationale and design.
    Lafeber M; Grobbee DE; Bots ML; Thom S; Webster R; Rodgers A; Visseren FL; Spiering W
    Eur J Prev Cardiol; 2014 Apr; 21(4):425-33. PubMed ID: 23382539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The polypill: optimal strategy for reduction of cardiovascular disease].
    Nathoe HM; Doevendans PA
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1740. PubMed ID: 16114290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?
    Krane V; Wanner C
    Am J Kidney Dis; 2005 Mar; 45(3):607-9. PubMed ID: 15754285
    [No Abstract]   [Full Text] [Related]  

  • 17. Underuse of antiplatelets and inappropriate use.
    Naunton M; Duyvendak M
    Eur J Clin Pharmacol; 2006 Jan; 62(1):81-2; author reply 79-80. PubMed ID: 16320046
    [No Abstract]   [Full Text] [Related]  

  • 18. Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
    Carlsson AC; Wändell P; Gasevic D; Sundquist J; Sundquist K
    Int J Cardiol; 2015; 187():547-52. PubMed ID: 25863300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Statins to Decrease HIV-Related Heart Disease Risk.
    Mitka M
    JAMA; 2015 Aug; 314(7):657-9. PubMed ID: 26222872
    [No Abstract]   [Full Text] [Related]  

  • 20. [The polypill: not an effective strategy for reduction of cardiovascular disease].
    Westerweel PE; van Wijk JP; Verhaar MC
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1741. PubMed ID: 16114291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.